Profile data is unavailable for this security.
About the company
Shanghai Haixin Group Co Ltd is a China-based diversified investment holding group that integrates pharmaceuticals, property leasing and management, textiles, and financial investment. The Company consists of five business segments. The main business and assets of the Investment segment are foreign investment. The Textile segment is mainly engaged in textile fabrics and clothing. The Medical segment is mainly engaged in the production and sales of pharmaceuticals, mainly chemical drugs. The Trading segment is mainly engaged in commodity goods trading. The Industrial Park segment is mainly engaged in real estate leasing and property management. The Company conducts business in the domestic market.
- Revenue in CNY (TTM)788.05m
- Net income in CNY156.25m
- Incorporated1993
- Employees715.00
- LocationShanghai Haixin Group Co LtdNo.688 Changxing RoadDongjing Town, Songjiang DistrictSHANGHAI 200001ChinaCHN
- Phone+86 2 163917000
- Fax+86 2 163917678
- Websitehttps://www.haixin.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kexing Biopharm Co Ltd | 1.52bn | 125.57m | 6.11bn | 947.00 | 48.25 | 3.51 | -- | 4.03 | 0.6288 | 0.6288 | 7.47 | 8.65 | 0.473 | 4.20 | 2.90 | 1,601,171.00 | 3.82 | -0.1893 | 5.31 | -0.2413 | 63.12 | 74.57 | 8.07 | -0.3956 | 1.38 | 63.54 | 0.4489 | -- | 11.75 | 3.39 | 116.54 | -27.74 | 11.90 | -- |
| Hunan Warrant Pharmaceutical Co Ltd | 1.43bn | 213.03m | 6.21bn | 1.24k | 29.15 | 3.12 | -- | 4.34 | 1.62 | 1.62 | 10.89 | 15.17 | 0.554 | 1.40 | 7.99 | 1,154,661.00 | 7.61 | 9.47 | 8.79 | 11.61 | 59.10 | 67.03 | 13.74 | 13.01 | 3.03 | -- | 0.1503 | 14.11 | -1.38 | 11.37 | -22.24 | 7.21 | 57.23 | -- |
| ChengDu Sheng Nuo Biotec Co Ltd | 638.35m | 120.09m | 6.25bn | 1.38k | 52.11 | 6.05 | -- | 9.78 | 0.7615 | 0.7615 | 4.09 | 6.56 | 0.3714 | 0.973 | 4.28 | 462,238.30 | 6.98 | 6.05 | 10.10 | 7.75 | 55.34 | 66.00 | 18.80 | 14.91 | 0.9008 | 14.11 | 0.3862 | 26.83 | 4.84 | 6.90 | -28.88 | 0.7741 | 51.66 | -- |
| Beijing Konruns Pharmaceutical Co Ltd | 871.31m | 57.12m | 6.59bn | 668.00 | 117.93 | 2.07 | -- | 7.56 | 0.3515 | 0.3515 | 5.55 | 20.06 | 0.2166 | 1.58 | 2.86 | 1,304,353.00 | 0.8033 | 3.82 | 0.9658 | 4.45 | 89.11 | 88.68 | 3.71 | 16.16 | 2.98 | -- | 0.0745 | 31.72 | -10.28 | -4.99 | -71.94 | -30.80 | 40.67 | -- |
| Shanghai Haixin Group Co Ltd | 788.05m | 156.25m | 6.67bn | 715.00 | 60.35 | 2.02 | -- | 8.46 | 0.1294 | 0.1294 | 0.6529 | 3.87 | 0.1404 | 5.99 | 8.40 | 1,102,168.00 | 3.13 | 2.89 | 3.42 | 3.27 | 51.52 | 46.43 | 22.33 | 12.82 | 4.42 | -- | 0.0209 | 35.43 | -32.70 | -6.47 | -9.09 | 7.75 | -34.08 | 5.92 |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 711.63m | -62.67m | 7.01bn | 925.00 | -- | 3.95 | -- | 9.86 | -0.0605 | -0.0605 | 0.6865 | 2.18 | 0.2795 | 2.02 | 2.18 | 769,331.60 | -2.47 | 5.01 | -2.70 | 6.20 | 88.90 | 91.92 | -8.83 | 14.50 | 8.51 | -11.45 | 0.007 | 48.29 | -16.61 | -7.17 | -63.42 | -29.45 | 1.11 | -- |
Data as of Feb 06 2026. Currency figures normalised to Shanghai Haixin Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
5.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Investment Corp. (Investment Management)as of 30 Sep 2025 | 22.60m | 3.06% |
| Chongqing International Trust Co., Ltd.as of 30 Sep 2025 | 20.76m | 2.81% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 285.10k | 0.04% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 59.40k | 0.01% |
| Western Leadbank Fund Management Co., Ltdas of 30 Jun 2025 | 48.60k | 0.01% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 36.70k | 0.01% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 18.30k | 0.00% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2025 | 13.10k | 0.00% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2025 | 11.30k | 0.00% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 9.00k | 0.00% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
